Tatva Chintan Pharma Chem Limited has informed the Exchange about Bagging/Receiving of orders/contracts

Export Order Hard CurrencyBusiness Updates View source PDF Explain this filing

TATVA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.0%Reaction day

₹704.20

prior close

₹688.05

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.5%+1.5% vs market

Specialty Chemicals peers, median of 81sector+0.7%+2.2% vs sector

On the reaction day the stock moved 1.5 pts more than Nifty Microcap 250 and 2.2 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.1

10m

+1.9

15m

+1.7

30m

+2.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.0+1.5+1.5+0.7+2.2

Next day

+4.4-1.2+5.6-1.6+6.0

+6.3+0.1+6.3-0.8+7.1

+2.2-0.8+3.0-2.1+4.3

+6.3-0.9+7.2-1.5+7.8

+9.1+3.7+5.4+2.4+6.8

+8.9+7.1+1.8+4.1+4.8

15d

+27.0+11.2+15.8+5.7+21.2

+33.1+13.2+19.9+10.2+22.9

+35.4+15.5+19.9+11.2+24.2

+62.5+12.7+49.7+6.3+56.1

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 81Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Tatva Chintan Pharma Chem has received an export order valued at USD 35,55,000 (approximately INR 29.95 Crores) excluding tax from an international client. The order is for the supply of specialty chemicals under the Pharma & Agro Intermediates & Specialty Chemicals (PASC) category. Delivery is scheduled for November–December 2025, which falls in Q3 FY26. The order is from an international entity and there is no promoter group or related party interest involved. The company announced this under SEBI's Listing Regulations disclosure requirements on May 5, 2025.

Likely market impact

This is a positive development as it strengthens the company's export order book and provides revenue visibility for Q3 FY26. USD-denominated orders also offer a natural hedge against rupee depreciation, which may be viewed favorably by investors.